Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

May 20, 2020 7:20 PM ET

Hereditary Angioedema Treatment Market to Reach US$ 6533.3 Mn by 2025, Improving Healthcare Infrastructure




iCrowd Newswire - May 20, 2020

Hereditary Angioedema Treatment Market Global, analyzes and researches the Instant Payments development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market.

The global “Hereditary Angioedema Treatment” market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, “Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.” As per the report, the global hereditary angioedema treatment market was worth US$ 1883.1 Mn in 2017. The global market is anticipated to expand at a CAGR of 16.8% and reach US$ 6533.3 Mn by the end of 2025. The report classifies the global hereditary angioedema treatment market in various segments and offer a comprehensive overview.

 

Key Players Operating in The Hereditary Angioedema Treatment Market Include:

 

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

 

 

 

 

 

 

 

Request a Sample Copy of Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hereditary-angioedema-treatment-market-100164

 

Highlights of the Report:

 

 

 

 

 

 

An Overview of the Impact of COVID-19 on this Market:

 

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

 

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

 

Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit:https://www.fortunebusinessinsights.com/industry-reports/hereditary-angioedema-treatment-market-100164

 

C-1 Esterase Inhibitor Segment to Dominate Global Market During Forecast Period

 

In terms of drug class, the C-1 esterase inhibitor is the most popular drug and dominated the global hereditary angioedema treatment market in 2017. The segment accounted for 61.3% of the global market in 2017. The trend is unlikely to change during the forecast period 2018-2025 owing to the drug’s reliability among patients and practitioners.

 

Increasing awareness about the disorder and rising prevalence of the hereditary angioedema are some factors expected to drive the global hereditary angioedema treatment market during the forecast period. Additionally, technological developments in the hereditary angioedema treatment devices and equipment is expected to boost the global market.

 

Shire, CSL Behring, and Pharming Group NV to Lead the Global Market

 

The global hereditary angioedema treatment market is witnessing entry of new players in the market. However, at present Pharming Group NV, Shire, and CSL Behring are together leading the global market owing to the organization’s strong distribution network. Some of the other companies operating in the global hereditary angioedema treatment market are BIOCRYST PHARMACEUTICALS INC., Ionis Pharmaceuticals Inc., Attune Pharmaceuticals, Arrowhead Pharmaceuticals Inc., and Adverum.

 

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hereditary-angioedema-treatment-market-100164

 

Detailed Table of Content:

 

 

 

 

 

 

 

 

Report Focus:

 

 

 

 

 

 

 

 

 

 

 

 

 

Reasons to Purchase this Report:

 

 

 

 

 

 

KEY QUESTIONS ANSWERED:

 

 

 

 

 

 

 

 

 

 

More Trending Topics from Fortune Business Insights:

 

Albumin Market

 

Wound Closure Market

 

Cosmetic Surgery Market

 

About Us:

 

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

 

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

 

Contact Us:

 

Fortune Business Insights™ Pvt. Ltd.

 

308, Supreme Headquarters,

 

Survey No. 36, Baner,

 

Pune-Bangalore Highway,

 

Pune – 411045, Maharashtra, India.

 

Phone:

 

US :+1 424 253 0390

 

UK : +44 2071 939123

 

APAC : +91 744 740 1245

 

Email:[email protected]

 

Linkedin|Twitter|BLogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Hereditary Angioedema Treatment Market to Reach US$ 6533.3 Mn by 2025, Improving Healthcare Infrastructure








iCrowdNewswire




Tags:    Wire, Research Newswire, English